KLK11 Polyclonal Antibody, PerCP Conjugated
Product Specifications
Background
Kallikrein 11 has two alternative splicing isoforms, known as the brain type and prostate type. Elevated serum levels of hK11 have been found in 70% of women with ovarian cancer and in 60% of men with prostate cancer. Analysis of this biomarker in serum may aid in the diagnosis and monitoring of ovarian and prostatic carcinoma.
Synonyms
Hippostasin; hK11; KLK 11; KLK-11; kallikrein 11; Kallikrein 11 isoform 1 preproprotein; Kallikrein 11 isoform 2 precursor; Kallikrein 11 precursor; kallikrein related peptidase 11; KLK 11; KLK11; Protease serine 20 trypsin like; Protease serine trypsin like; PRSS20; Serine protease 20; TLSP; Trypsin like protease; KLK11_HUMAN.
Gene ID
11012
Cellular Locus
Cytoplasm, Secreted
Host
Rabbit
Cross Reactivity
Human
Immunogen
201-282/282
Target
KLK11
Clonality
Polyclonal
Isotype
IgG
Conjugation
PerCP
Source
KLH conjugated synthetic peptide derived from human KLK11
Applications
WB, IF (IHC-P), IF (IHC-F), IF (ICC)
Purification
Purified by Protein A.
Excitation Emission
482nm/677nm
Concentration
1µg/µl
Dilution
WB (1:300-5000), IF (IHC-P) (1:50-200), IF (IHC-F) (1:50-200), IF (ICC) (1:50-200)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
11012
Predicted Cross Reactivity
Mouse, Rat, Dog
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
AY257033-01 50 µg
Anti-Ocrelizumab Non-Neutralizing Recombinant Antibody (SAA2633)
Sign In for Pricing
View Details AY257033-02 100 µg
Anti-Ocrelizumab Non-Neutralizing Recombinant Antibody (SAA2633)
Sign In for Pricing
View Details 